Pharmacokinetics, Immunogenicity and Safety Study for SHR-1309 Injection and Perjeta® in Healthy Chinese Male Volunteers

Objectives: Pertuzumab is a monoclonal antibody for the treatment of breast cancer. The aim of this study was to compare the pharmacokinetics, immunogenicity and safety of the test preparation SHR-1309 injecta and the reference preparation Perjeta® in healthy Chinese male subjects. Methods: In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Yingzi, Cui, Dongyang, Ren, Xinran, Chen, Xuesong, Liu, Guangwen, Liu, Zhengzhi, Wang, Yanli, Qu, Xinyao, Zhao, Yicheng, Yang, Haimiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207516/
https://www.ncbi.nlm.nih.gov/pubmed/34149414
http://dx.doi.org/10.3389/fphar.2021.660541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207516/
https://www.ncbi.nlm.nih.gov/pubmed/34149414
http://dx.doi.org/10.3389/fphar.2021.660541

Ejemplares similares